Notes on Cyclooxygenase Inhibitors and Their Use

Cyclooxygenase Forms

  • COX-1: Present in most tissues, regulates normal physiological functions.
  • COX-2: Primarily produced at sites of tissue injury, associated with inflammation.

Cyclooxygenase Function

  • Converts arachidonic acid into prostanoids, specifically prostaglandins, which mediate inflammatory responses such as:
    • Rubor: Redness
    • Calor: Heat
    • Dolor: Pain

Cyclooxygenase Inhibitors

  • Two Groups of Inhibitors:
    1. Drugs with anti-inflammatory properties - NSAIDs
    • Examples: Aspirin (ASA), Ibuprofen, Naproxen, Celecoxib
    • Subgroups:
      • First-Generation NSAIDs: Non-selective (inhibit both COX-1 & COX-2)
      • Second-Generation NSAIDs: Selective for COX-2
    1. Drugs without anti-inflammatory properties - Acetaminophen

Classification of NSAIDs

Drugs with Anti-Inflammatory Properties
  • NSAIDs include:
    • Aspirin
    • Celecoxib
    • Ibuprofen
    • Naproxen
Drugs without Anti-Inflammatory Properties
  • Acetaminophen: No significant anti-inflammatory action.

First-Generation NSAIDs

  • Functionality:
    • Inhibit both COX-1 and COX-2.
    • Used for treating inflammatory disorders (e.g., rheumatoid arthritis, osteoarthritis, bursitis).
    • Alleviate mild to moderate pain.
    • Suppress fever.
    • Suppress inflammation but can pose risks of serious harm.
Aspirin
  • Characteristics:

    • Nonselective inhibitor of cyclooxygenase.
    • Therapeutic uses: analgesic, antipyretic, anti-inflammatory.
    • Unique action: Protects against myocardial infarction (MI) and stroke due to antiplatelet effects.
  • Adverse Effects:

    • Gastrointestinal issues (e.g., gastric upset, bleeding)
    • Renal impairment
    • Salicylism
    • Reye’s syndrome (not recommended for children)
    • Hypersensitivity reactions
  • Drug Interactions:

    • Anticoagulants (e.g., warfarin, heparin)
    • Glucocorticoids
    • Alcohol
    • Ibuprofen
    • ACE inhibitors and ARBs
    • Risks of acute poisoning.
Non-Aspirin First-Generation NSAIDs
  • Characteristics:
    • Similar to aspirin but with fewer gastrointestinal and renal side effects.
    • Examples include Ibuprofen (Advil, Motrin).

Ibuprofen

  • Properties:

    • Inhibits cyclooxygenase, providing anti-inflammatory, analgesic, and antipyretic effects.
    • Indicated for fever, mild to moderate pain, arthritis.
    • Generally well tolerated; low incidence of adverse effects.
  • Safety Alert: All first-generation NSAIDs carry an increased risk of GI bleeding.

Second-Generation NSAIDs

  • Overview:
    • Effective in suppressing inflammation and pain, similar to traditional NSAIDs.
    • Lower risk for gastrointestinal side effects but may impair renal function, leading to hypertension and edema.
    • Increased risk for myocardial infarction (MI) and stroke.
Celecoxib (Celebrex)
  • Usage:

    • Effective for osteoarthritis, rheumatoid arthritis, acute pain, dysmenorrhea, familial adenomatous polyposis.
    • Considered a last-choice drug for long-term pain management due to cardiovascular risks.
  • Adverse Effects:

    • GI ulceration
    • Renal impairment
    • Sulfonamide allergy
    • Cardiovascular effects (e.g., stroke, MI)
    • Contraindicated in pregnancy.
  • Drug Interactions:

    • Warfarin (risk of increased bleeding)
    • Diuretics (e.g., furosemide)
    • Antihypertensives (ACE inhibitors)
    • Levels of celecoxib may increase with fluconazole.

Acetaminophen (Tylenol)

  • Therapeutic Uses:

    • Analgesic, antipyretic.
    • No anti-inflammatory or antirheumatic properties.
    • Not associated with Reye’s syndrome.
  • Mechanism of Action:

    • Inhibits prostaglandin synthesis in the central nervous system.
  • Adverse Effects:

    • Very few at normal doses.
    • Risks of hepatotoxicity with overdose or in patients with liver failure.
    • Signs of overdose include nausea, vomiting, diarrhea, abdominal pain.
    • Treatment for overdose: acetylcysteine (Mucomyst).
  • Drug Interactions:

    • Alcohol
    • Warfarin

American Heart Association (AHA) Position

  • Most COX inhibitors, especially COX-2 inhibitors, increase the risk for MI and stroke.
  • AHA recommends a stepped-care approach for managing pain and inflammation, considering cardiovascular risks.